These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23312000)

  • 1. Effect of amlodipine on the pharmacokinetics of tacrolimus in rats.
    Zhou YN; Zhang BK; Li J; Zuo XC; Yuan H; Yang GP; Cheng ZN; Liu Z; Li PJ; Tan HY; Zhou LY; Wang CJ; Yang M
    Xenobiotica; 2013 Aug; 43(8):699-704. PubMed ID: 23312000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term co-administration of Wuzhi tablet (Schisandra sphenanthera extract) and prednisone on the pharmacokinetics of tacrolimus.
    Qin XL; Yu T; Li LJ; Wang Y; Gu HM; Wang YT; Huang M; Bi HC
    Phytomedicine; 2013 Feb; 20(3-4):375-9. PubMed ID: 23267661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of traditional Chinese medicine colquhounia root tablet on the pharmacokinetics of tacrolimus in rats.
    Feng X; Shi Y; Ding Y; Zheng H
    J Ethnopharmacol; 2022 Aug; 294():115358. PubMed ID: 35551976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus.
    von Suesskind-Schwendi M; Gruber M; Touraud D; Kunz W; Schmid C; Hirt SW; Lehle K
    Biomed Pharmacother; 2013 Jul; 67(6):469-73. PubMed ID: 23669280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of morin on the pharmacokinetics of nicardipine after oral and intravenous administration of nicardipine in rats.
    Piao YJ; Choi JS
    J Pharm Pharmacol; 2008 May; 60(5):625-9. PubMed ID: 18416939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats.
    Lee CK; Choi JS
    Pharmacology; 2010; 85(6):350-6. PubMed ID: 20523105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin.
    Cho YA; Lee W; Choi JS
    Pharmazie; 2012 Feb; 67(2):124-30. PubMed ID: 22512082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of P-glycoprotein in the hepatic metabolism of tacrolimus.
    Jeong H; Chiou WL
    Xenobiotica; 2006 Jan; 36(1):1-13. PubMed ID: 16507509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
    Musuamba FT; Mourad M; Haufroid V; Delattre IK; Verbeeck RK; Wallemacq P
    Ther Drug Monit; 2009 Dec; 31(6):734-42. PubMed ID: 19855314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
    Choi YH; Suh JH; Lee JH; Cho IH; Lee MG
    J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.
    Li X; Choi JS
    Int J Pharm; 2007 Jun; 337(1-2):188-93. PubMed ID: 17267149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
    Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T
    Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition effect of epigallocatechin-3-gallate on the pharmacokinetics of calcineurin inhibitors, tacrolimus, and cyclosporine A, in rats.
    Huang X; Zhang R; Yang T; Wei Y; Yang C; Zhou J; Liu Y; Shi S
    Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):121-134. PubMed ID: 33054444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of silybinin, CYP3A4 and P-glycoprotein inhibitor in vitro, on the bioavailability of loratadine in rats.
    Li C; Lee MY; Choi JS
    Pharmazie; 2010 Jul; 65(7):510-4. PubMed ID: 20662320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506).
    Qin XL; Bi HC; Wang XD; Li JL; Wang Y; Xue XP; Chen X; Wang CX; Xu le J; Wang YT; Huang M
    Int J Pharm; 2010 Apr; 389(1-2):114-21. PubMed ID: 20097278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of morin on the pharmacokinetics of etoposide in rats.
    Li X; Yun JK; Choi JS
    Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol.
    Choi JS; Choi BC; Kang KW
    Pharmazie; 2009 Jan; 64(1):49-52. PubMed ID: 19216231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems.
    Wang Y; Sun J; Zhang T; Liu H; He F; He Z
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1225-30. PubMed ID: 21615281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher intracerebral concentration of tacrolimus after intermittent than continuous administration to rats.
    Sakamoto Y; Makuuchi M; Harihara Y; Imamura H; Sato H
    Liver Transpl; 2001 Dec; 7(12):1071-6. PubMed ID: 11753909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus.
    Shimomura M; Masuda S; Saito H; Sakamoto S; Uemoto S; Tanaka K; Inui K
    J Surg Res; 2002 Apr; 103(2):215-22. PubMed ID: 11922737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.